ARCHIVES

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

This article is from The Cancer Letter archive.

Vol. 24 No. 25 | June 26, 1998

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI CTEP During July

August 30, 2002

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014

Funding opportunities listed.

July 23, 2004

A Year at NCI: Harold Varmus Reflects On Provocative Questions, The Duke Scandal, Financial Disaster And Grant Review

July 22, 2011

Obituary: Lee Wattenberg, 92, “Father of Chemoprevention”

December 12, 2014

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

March 14, 2008